Humanigen Inc (fka HGENQ)

[DonDonDonDon]

I also believe in the “There’s room for more than 1 therapy“ approach.

There is room for 20 treatments if they are good. But they aren't going to approve a drug without good efficacy just because there is a need. They already did that with remdesivir. They aren't doing it again.

My guess is that there will be a bunch of different antiviral drugs that will get EUAs for the early stages of Covid. A bunch have already shown good efficacy. But lenzilumab is going to be the main drug used for the advanced stages. The Imperial College London study showed definitively that GM-CSF is responsible for the cytokine storm. Lenz has the correct MOA.

https://www.bbc.com/news/health-56352128

https://immunology.sciencemag.org/content/6/57/eabg9873